Papers and Presentations
How to Search for Resources
You can search for a variety of content on the CASSS website. CASSS makes available any content with author approval. Narrow your search by using the various filters shown below, such as Resource Type, Event Type, and Year. Refine your search as needed.
Refine Results
Filter By Resource Type
Filter By Event Types
- WCBP (461)
- Cell & Gene Therapy Products (230)
- CE Pharm (213)
- Mass Spectrometry (201)
- CMC Strategy Forum Europe (196)
- Bioassays (134)
- Higher Order Structure (109)
- AT Europe (109)
- CMC Strategy Forum Japan (105)
- CMC Strategy Forum (78)
- CMC Strategy Forum North America Winter (77)
- CMC Strategy Forum North America Summer (72)
- CMC Strategy Forum Latin America (51)
- CGTP Summit (37)
- CMC Strategy Forum China (29)
- Consultants' Network (16)
- CMC Strategy Forum North America Fall (14)
- CGTP Europe (11)
- Symposium on mRNA (11)
- Virtual Summit: Bioconjugates (9)
- Virtual Summit: Manufacturing (8)
- Biophysics Working Group (8)
- Virtual Europe Discussion Group (8)
- CGTP Virtual Summit (7)
- NorCal Regional Forum (6)
- Netherlands Area Biotech Discussion Group (5)
- DC Area Scientific Discussion Group (4)
- Biotech Working Group (2)
- Midwest Regional Forum (2)
- CMC-Vaccines Working Group (1)
- Exhibitor Webinars (1)
Filter By Tags
-
CGTP 2026 Scientific Program
Scientific Program: CGTP 2026 -
Rethinking Specification Setting in Autologous Cell and Gene Therapies: From Variability to Global Alignment
Speaker Presentation: CGTP Summit 2026 Suravajhala Shilpa, Vertex Pharmaceuticals Incorporated, 2026 -
Regulatory Perspectives on Establishing Specifications for Cell and Gene Therapy Products: From Speculation to Specification
Speaker Presentation: CGTP Summit 2026Price Graeme, CBER, FDA, 2026 -
Evergreen Specification Setting Practices
Speaker Presentation: CGTP Summit 2026O'Neil Julia, Direxa Consulting, 2026 -
Life Cycle‑Aligned Specifications: Ensuring Quality and Consistency in Cell and Gene Therapy Development
Speaker Presentation: CGTP Summit 2026Lucas Tiffany, ELIQUENT Life Sciences, 2026 -
Between Scylla and Charybdis: Navigating Specification Setting for Rare and Ultra Rare Disease Programs
Speaker Presentation: CGTP Summit 2026Kidder Joshua, Ultragenyx Pharmaceutical Inc., 2026 -
Rethinking Product Release Specifications for Autologous CAR T Cell Therapy
Speaker Presentation: CGTP Summit 2026Dave Kedar, Bristol-Myers Squibb Company, 2026 -
CGTP Summit 2026 Summary Infographic
Summary Infographic: CGTP Summit 2026 -
CGTP Summit 2026 Scientific Program
Scientific Program: CGTP Summit 2026 -
Comparability Risk Mitigation: Identification of a New Low-Level Heavy-Heavy Chain Variant in an ADC
Speaker Presentation: Virtual Summit: Bioconjugates 2026Wang Yazhe, Merck & Co., Inc., 2026 -
Analytical Comparability Approach for an Antibody Drug Conjugate
Speaker Presentation: Virtual Summit: Bioconjugates 2026Flick Tawnya, Gilead Sciences, Inc., 2026 -
Development and Characterization of Antibody-Oligonucleotides Conjugate Manufacturing Processes
Speaker Presentation: Virtual Summit: Bioconjugates 2026Martini Mitch, Avidity Biosciences, Inc., … -
Virtual Summit Bioconjugates 2026 Summary Infographic
Summary Infographic: Virtual Summit Bioconjugates 2026 -
CMC Regulatory Considerations for Antibody-Drug Conjugates (ADCs) – From the Biologics Perspective
Speaker Presentation: Virtual Summit: Bioconjugates 2026Zhang Nailing, FDA, 2026 -
Charge Variant Control Strategy for Late-Stage Antibody Drug Conjugates
Speaker Presentation: Virtual Summit: Bioconjugates 2026Sowers Carrie, AstraZeneca, 2026 -
Managing Bioconjugate Heterogeneity Related to Drug-Linkers
Speaker Presentation: Virtual Summit: Bioconjugates 2026Cole Kevin, Eli Lilly and Company, 2026 -
Impurity Qualification Requirements for Drug-Linkers Related Impurities Used to Generate Antibody-Drug Conjugates
Speaker Presentation: Virtual Summit: Bioconjugates 2026Chahrour Osama, AstraZeneca, 2026 -
Virtual Summit Bioconjugates 2026 Scientific Program
Scientific Program: Virtual Summit Bioconjugates 2026 -
Challenges and Opportunities for Assessing Stability of Emerging Modalities
Speaker Presentation: VEDG 2026Oita Iulia, Ziphius Vaccines, 2026 -
Accelerated Stability Prediction for Biotherapeutic
Speaker Presentation: VEDG 2026Kuzman Drago, Novartis AG, 2026